
Jeffrey E. Russel
Examiner (ID: 13185, Phone: (571)272-0969 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1815, 1103, 1621, 1811, 1653, 1675, 2899, 1654, 1809 |
| Total Applications | 3437 |
| Issued Applications | 2371 |
| Pending Applications | 237 |
| Abandoned Applications | 837 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6445962
[patent_doc_number] => 20100279923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-04
[patent_title] => 'THERAPEUTIC APPLICATION OF KAZAL-TYPE SERINE PROTEASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/526758
[patent_app_country] => US
[patent_app_date] => 2008-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12088
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0279/20100279923.pdf
[firstpage_image] =>[orig_patent_app_number] => 12526758
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/526758 | Therapeutic application of Kazal-type serine protease inhibitors | Feb 10, 2008 | Issued |
Array
(
[id] => 4786133
[patent_doc_number] => 20080139462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-12
[patent_title] => 'TREATMENT OF MEMBRANE-ASSOCIATED DISEASES AND DISORDERS USING LANTIBIOTIC CONTAINING COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/026358
[patent_app_country] => US
[patent_app_date] => 2008-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16103
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0139/20080139462.pdf
[firstpage_image] =>[orig_patent_app_number] => 12026358
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/026358 | TREATMENT OF MEMBRANE-ASSOCIATED DISEASES AND DISORDERS USING LANTIBIOTIC CONTAINING COMPOSITIONS | Feb 4, 2008 | Abandoned |
Array
(
[id] => 5546747
[patent_doc_number] => 20090156624
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-18
[patent_title] => 'Methionine aminopeptidase-2 inhibitors and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/011685
[patent_app_country] => US
[patent_app_date] => 2008-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17791
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20090156624.pdf
[firstpage_image] =>[orig_patent_app_number] => 12011685
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/011685 | Methionine aminopeptidase-2 inhibitors and methods of use thereof | Jan 28, 2008 | Abandoned |
Array
(
[id] => 4664341
[patent_doc_number] => 20080255248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'Prodrug compounds with isoleucine'
[patent_app_type] => utility
[patent_app_number] => 12/009031
[patent_app_country] => US
[patent_app_date] => 2008-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 22596
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20080255248.pdf
[firstpage_image] =>[orig_patent_app_number] => 12009031
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/009031 | Prodrug compounds with isoleucine | Jan 15, 2008 | Issued |
Array
(
[id] => 4904502
[patent_doc_number] => 20080113916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-15
[patent_title] => 'Povidone-Containing Carriers for Polypeptide Growth Factors'
[patent_app_type] => utility
[patent_app_number] => 12/013517
[patent_app_country] => US
[patent_app_date] => 2008-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7084
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20080113916.pdf
[firstpage_image] =>[orig_patent_app_number] => 12013517
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/013517 | Povidone-Containing Carriers for Polypeptide Growth Factors | Jan 13, 2008 | Abandoned |
Array
(
[id] => 12673
[patent_doc_number] => 07807141
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-05
[patent_title] => 'Peptide-based oral care surface reagents for personal care'
[patent_app_type] => utility
[patent_app_number] => 11/971975
[patent_app_country] => US
[patent_app_date] => 2008-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29865
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/807/07807141.pdf
[firstpage_image] =>[orig_patent_app_number] => 11971975
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/971975 | Peptide-based oral care surface reagents for personal care | Jan 9, 2008 | Issued |
Array
(
[id] => 4664145
[patent_doc_number] => 20080255052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'Immunologic regulation by theta defensins'
[patent_app_type] => utility
[patent_app_number] => 12/006991
[patent_app_country] => US
[patent_app_date] => 2008-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 14203
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20080255052.pdf
[firstpage_image] =>[orig_patent_app_number] => 12006991
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/006991 | Immunologic regulation by theta defensins | Jan 6, 2008 | Abandoned |
Array
(
[id] => 4965757
[patent_doc_number] => 20080108577
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-08
[patent_title] => 'Tissue adhering compositions'
[patent_app_type] => utility
[patent_app_number] => 12/004964
[patent_app_country] => US
[patent_app_date] => 2007-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8325
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20080108577.pdf
[firstpage_image] =>[orig_patent_app_number] => 12004964
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/004964 | Tissue adhering compositions | Dec 20, 2007 | Issued |
Array
(
[id] => 6443607
[patent_doc_number] => 20100144596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'An Apo-Ferredoxin Preparation, A Process For Producing Same And Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/448358
[patent_app_country] => US
[patent_app_date] => 2007-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5974
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20100144596.pdf
[firstpage_image] =>[orig_patent_app_number] => 12448358
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/448358 | An Apo-Ferredoxin Preparation, A Process For Producing Same And Uses Thereof | Dec 17, 2007 | Abandoned |
Array
(
[id] => 4571
[patent_doc_number] => 07811995
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-12
[patent_title] => 'Therapeutic and diagnostic peptides'
[patent_app_type] => utility
[patent_app_number] => 11/955226
[patent_app_country] => US
[patent_app_date] => 2007-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 10
[patent_no_of_words] => 8510
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/811/07811995.pdf
[firstpage_image] =>[orig_patent_app_number] => 11955226
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/955226 | Therapeutic and diagnostic peptides | Dec 11, 2007 | Issued |
Array
(
[id] => 4739428
[patent_doc_number] => 20080233081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'PRO-ANGIOGENIC PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 11/955143
[patent_app_country] => US
[patent_app_date] => 2007-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6700
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20080233081.pdf
[firstpage_image] =>[orig_patent_app_number] => 11955143
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/955143 | Pro-angiogenic peptides | Dec 11, 2007 | Issued |
Array
(
[id] => 4746167
[patent_doc_number] => 20080090769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-17
[patent_title] => 'TREATMENT OF PSORIASIS THROUGH DOWN-REGULATION OF THE EGF-RECEPTOR WITH TOPICALLY APPLIED EGF'
[patent_app_type] => utility
[patent_app_number] => 11/954006
[patent_app_country] => US
[patent_app_date] => 2007-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 588
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20080090769.pdf
[firstpage_image] =>[orig_patent_app_number] => 11954006
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/954006 | TREATMENT OF PSORIASIS THROUGH DOWN-REGULATION OF THE EGF-RECEPTOR WITH TOPICALLY APPLIED EGF | Dec 10, 2007 | Abandoned |
Array
(
[id] => 4753169
[patent_doc_number] => 20080161244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-03
[patent_title] => 'Analogs of gastric inhibitory polypeptide and their use for treatment of diabetes'
[patent_app_type] => utility
[patent_app_number] => 12/001449
[patent_app_country] => US
[patent_app_date] => 2007-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 7143
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20080161244.pdf
[firstpage_image] =>[orig_patent_app_number] => 12001449
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/001449 | Analogs of gastric inhibitory polypeptide and their use for treatment of diabetes | Dec 10, 2007 | Issued |
Array
(
[id] => 4965756
[patent_doc_number] => 20080108576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-08
[patent_title] => 'Novel cytostatic conjugates with integrin ligands'
[patent_app_type] => utility
[patent_app_number] => 11/999445
[patent_app_country] => US
[patent_app_date] => 2007-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20154
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20080108576.pdf
[firstpage_image] =>[orig_patent_app_number] => 11999445
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/999445 | Novel cytostatic conjugates with integrin ligands | Dec 3, 2007 | Abandoned |
Array
(
[id] => 4792665
[patent_doc_number] => 20080293639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-27
[patent_title] => 'PEPTIDES AND PEPTIDE MIMETICS TO TREAT PATHOLOGIES CHARACTERIZED BY AN INFLAMMATORY RESPONSE'
[patent_app_type] => utility
[patent_app_number] => 11/950315
[patent_app_country] => US
[patent_app_date] => 2007-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 48266
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20080293639.pdf
[firstpage_image] =>[orig_patent_app_number] => 11950315
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/950315 | PEPTIDES AND PEPTIDE MIMETICS TO TREAT PATHOLOGIES CHARACTERIZED BY AN INFLAMMATORY RESPONSE | Dec 3, 2007 | Abandoned |
Array
(
[id] => 8621635
[patent_doc_number] => 08354549
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-15
[patent_title] => 'Method for preparing a polymer conjugate'
[patent_app_type] => utility
[patent_app_number] => 12/515736
[patent_app_country] => US
[patent_app_date] => 2007-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 10091
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12515736
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/515736 | Method for preparing a polymer conjugate | Nov 29, 2007 | Issued |
Array
(
[id] => 52731
[patent_doc_number] => 07771962
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-10
[patent_title] => 'CD10-activated prodrug compounds'
[patent_app_type] => utility
[patent_app_number] => 11/986096
[patent_app_country] => US
[patent_app_date] => 2007-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 38102
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/771/07771962.pdf
[firstpage_image] =>[orig_patent_app_number] => 11986096
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/986096 | CD10-activated prodrug compounds | Nov 19, 2007 | Issued |
Array
(
[id] => 4808121
[patent_doc_number] => 20080171699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-17
[patent_title] => 'Novel cyclic peptides'
[patent_app_type] => utility
[patent_app_number] => 11/986078
[patent_app_country] => US
[patent_app_date] => 2007-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18772
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20080171699.pdf
[firstpage_image] =>[orig_patent_app_number] => 11986078
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/986078 | Cyclic peptides | Nov 18, 2007 | Issued |
Array
(
[id] => 7987991
[patent_doc_number] => 08076290
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-13
[patent_title] => 'Stabilizing alkylglycoside compositions and methods thereof'
[patent_app_type] => utility
[patent_app_number] => 11/937966
[patent_app_country] => US
[patent_app_date] => 2007-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19580
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/076/08076290.pdf
[firstpage_image] =>[orig_patent_app_number] => 11937966
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/937966 | Stabilizing alkylglycoside compositions and methods thereof | Nov 8, 2007 | Issued |
Array
(
[id] => 5368669
[patent_doc_number] => 20090306228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'ACTIVE AGENT DELIVERY SYSTEMS AND METHODS FOR PROTECTING AND ADMINISTERING ACTIVE AGENTS'
[patent_app_type] => utility
[patent_app_number] => 11/933846
[patent_app_country] => US
[patent_app_date] => 2007-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 46
[patent_no_of_words] => 91204
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20090306228.pdf
[firstpage_image] =>[orig_patent_app_number] => 11933846
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/933846 | ACTIVE AGENT DELIVERY SYSTEMS AND METHODS FOR PROTECTING AND ADMINISTERING ACTIVE AGENTS | Oct 31, 2007 | Abandoned |